Feng Xia

No. 1095, Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 154 publications

Consensus on standardized later-line systemic therapy for hepatocellular carcinoma.

Consensus on standardized later-line systemic therapy for hepatocellular carcinoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: May 11, 2026

Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis.

Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis.

Journal: Biomedicines

Published: March 01, 2026

The surgical outcomes of modified Chen's U-suture technique compared with duct-to-mucosa anastomosis in laparoscopic pancreaticoduodenectomy: a multi-center cohort study.

The surgical outcomes of modified Chen's U-suture technique compared with duct-to-mucosa anastomosis in laparoscopic pancreaticoduodenectomy: a multi-center cohort study.

Journal: Surgical endoscopy

Published: February 21, 2026

Long-Term Outcome of No-Touch Radiofrequency Ablation for Treating AFP-Positive Small Hepatocellular Carcinoma.

Long-Term Outcome of No-Touch Radiofrequency Ablation for Treating AFP-Positive Small Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: February 20, 2026

Impact of age on safety of pancreaticoduodenectomy: a nationwide cohort study stratified by surgical approach and anastomotic technique with optimal age cut-off analysis.

Impact of age on safety of pancreaticoduodenectomy: a nationwide cohort study stratified by surgical approach and anastomotic technique with optimal age cut-off analysis.

Journal: Science China. Life sciences

Published: February 10, 2026

Development and Internal Multicenter Validation of a Deep Learning Model for Predicting Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma: A Multicenter Study.

Development and Internal Multicenter Validation of a Deep Learning Model for Predicting Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma: A Multicenter Study.

Journal: Cancers

Published: February 05, 2026

Predictive Value of Age-Adjusted Charlson Comorbidity Index on Survival Outcomes of Hepatocellular Carcinoma Patients with Comorbidities Undergoing Radiofrequency Ablation.

Predictive Value of Age-Adjusted Charlson Comorbidity Index on Survival Outcomes of Hepatocellular Carcinoma Patients with Comorbidities Undergoing Radiofrequency Ablation.

Journal: Journal of hepatocellular carcinoma

Published: January 30, 2026

Short- and Long-Term Outcomes of Radiofrequency Ablation for Early Hepatocellular Carcinoma with Liver Dysfunction.

Short- and Long-Term Outcomes of Radiofrequency Ablation for Early Hepatocellular Carcinoma with Liver Dysfunction.

Journal: Journal of hepatocellular carcinoma

Published: January 01, 2026

No-touch versus conventional radiofrequency ablation for treating solitary recurrent hepatocellular carcinoma ≤ 3 cm: a retrospective cohort study.

No-touch versus conventional radiofrequency ablation for treating solitary recurrent hepatocellular carcinoma ≤ 3 cm: a retrospective cohort study.

Journal: Journal of cancer research and clinical oncology

Published: November 04, 2025

Development and external validation of a novel online calculator for predicting long-term survival following radical hepatectomy in patients with BCLC stage 0/A hepatocellular carcinoma and clinically significant portal hypertension.

Development and external validation of a novel online calculator for predicting long-term survival following radical hepatectomy in patients with BCLC stage 0/A hepatocellular carcinoma and clinically significant portal hypertension.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 07, 2025

Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma.

Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma.

Journal: Annals of surgical oncology

Published: August 26, 2025

Clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection in BCLC 0/A hepatocellular carcinoma: a nationwide cohort study.

Clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection in BCLC 0/A hepatocellular carcinoma: a nationwide cohort study.

Journal: International journal of surgery (London, England)

Published: June 11, 2025

Showing 1-12 of 154

Last Updated: 09/26/2026